Advertisement
UK markets close in 5 hours 7 minutes
  • FTSE 100

    8,112.85
    +33.99 (+0.42%)
     
  • FTSE 250

    19,826.45
    +224.47 (+1.15%)
     
  • AIM

    755.59
    +2.47 (+0.33%)
     
  • GBP/EUR

    1.1661
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2519
    +0.0008 (+0.06%)
     
  • Bitcoin GBP

    51,479.54
    +692.94 (+1.36%)
     
  • CMC Crypto 200

    1,392.32
    -4.21 (-0.30%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     
  • GOLD FUTURES

    2,360.40
    +17.90 (+0.76%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,050.14
    +132.86 (+0.74%)
     
  • CAC 40

    8,038.86
    +22.21 (+0.28%)
     

$175+ Million Dual Chamber Prefilled Syringes Market, 2025 by Material (Glass, Plastic) & Product (Liquid/Powder, Liquid/Liquid)

Dublin, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Dual Chamber Prefilled Syringes Market by Material (Glass, Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, Diabetes), Product (Liquid/Powder, Liquid/Liquid) and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global size of the dual chamber prefilled syringes market was USD 125 million in 2019 and is projected to reach USD 182 million by 2025, registering a CAGR of 6.8% from 2020.

The leading players in the industry are Nipro Corporation (Japan), Gerresheimer AG (Germany), Vetter Pharma (Germany), Credence Medsystems (US), MAEDA INDUSTRY (Japan), and Arte Corporation (Japan).

The global dual chamber prefilled syringes market is witnessing growth because of the growing demand for drug delivery systems, with the growing pharmaceutical industry in the emerging economies. The increasing number of lyophilized drugs is another reason for the growing demand for dual chamber prefilled syringes, as this type of drug delivery system increases the life of the drug.

Dual chamber prefilled syringes are syringes that have two partitioned chambers, where the front chamber can be filled with a lyophilized drug product and the back chamber with its diluent, or both the chambers can be filled with drug products intended for co-delivery.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary
Hemophilia Accounted for the Largest Share in 2019
Glass Segment Accounted for the Larger Share in 2019
North America to Register the Highest Growth During the Forecast Period
Drug Delivery Device Ecosystem

4 Premium Insights
4.1 Attractive Growth Opportunities for Dual Chamber Prefilled Syringes Market
4.2 North America Dual Chamber Prefilled Syringes Market
4.3 Dual Chamber Prefilled Syringes Market, by Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Biopharmaceutical Industry
5.2.1.2 Growing Demand for Drug Delivery Devices for Lyophilic Drugs
5.2.1.3 Lesser Risk of Contamination
5.2.1.4 Growing Health Awareness and Adoption of New Regulatory Standards
5.2.2 Restraints
5.2.2.1 Risk of Cross-Contamination
5.2.2.2 Increasing Overall Packaging Costs Owing to Dynamic Regulatory Policies
5.2.2.3 Lack of Access and Awareness in Emerging Markets
5.2.3 Opportunities
5.2.3.1 Making the Separable Dual Chamber Prefilled Syringe Cost-Effective
5.2.4 Challenges
5.2.4.1 Safeguarding Against Counterfeit Products
5.3 Porter's Five Forces Analysis
5.4 Value Chain of the Dual Chamber Prefilled Syringes
5.5 Yc, Ycc Drivers
5.5.1 Consumer Preference and Impact of Industry 4.0
5.5.2 Emerging Trends and Technologies Impacting Materials in the Pharmaceutical Industry
5.6 Ecosystem Mapping
5.7 COVID-19 Impact on Vaccines & Drugs
5.7.1 COVID-19 Health Assessment
5.7.2 COVID-19: Economic Assessment
5.8 COVID-19 Impact on the Economy - Scenario Assessment
5.9 COVID-19: Development of Vaccines
5.9.1 Current Pipeline of Vaccines
5.9.1.1 Viewpoint on the COVID-19 Pipeline
5.1 Post-COVID-19 Vaccine Approval Scenario
5.10.1 Challenges in Vaccine Approval/Production/Supply
5.10.1.1 Are Companies Taking Enough Advantage of Artificial Intelligence (AI) to Fast Track Vaccine/Drug Approval? (Medium Criticality)
5.10.1.2 Can Production for Pandemics Be a Challenge? (High Criticality)
5.10.1.3 The World Needs a Vaccine But Who Needs It the Most? (Medium Criticality)
5.10.1.3.1 New Strategies
5.10.1.4 New Opportunities
5.10.1.4.1 Investments in Real-World Evidence by Pharmaceutical Companies
5.10.1.5 Trends
5.10.1.5.1 Changes in IPR to Promote the Supply of Essential Drugs and Medical Supplies

6 Dual Chamber Prefilled Syringes Market, by Application
6.1 Introduction
6.2 Liquid/Powder
6.3 Liquid/Liquid

7 Dual Chamber Prefilled Syringes Market, by Product
7.1 Introduction
7.2 &lessThan;1 Ml
7.3 1-2.5 Ml
7.4 2.5-5 Ml
7.5 >5 Ml

8 Dual Chamber Prefilled Syringes Market, by Material
8.1 Introduction
8.2 Glass
8.3 Plastic

9 Dual Chamber Prefilled Syringes Market, by Indication
9.1 Introduction
9.2 Hemophilia
9.3 Schizophrenia
9.4 Diabetes
9.5 Erectile Dysfunction
9.6 Endometriosis
9.7 Others

10 Dual Chamber Prefilled Syringes Market, by Region

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Company Evaluation Matrix
11.3.1 Pervasive
11.3.2 Emerging Leaders
11.3.3 Star
11.3.4 Emerging Players

12 Company Profiles
12.1 Gerresheimer AG
12.2 Vetter Pharma
12.3 Nipro Corporation
12.4 Credence Medsystems
12.5 MAEDA Industry
12.6 Arte Corporation

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/muu03j

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900